A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity
Clinical trial NCT04222790 · COMPLETED
Trial details
- NCT number
- NCT04222790
- Sponsor
- Henan Cancer Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2022-04-21
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.